Type of Beta-blocker Use Among Patients with Versus without Diabetes after Myocardial Infarction

BACKGROUND: Discharge beta-blocker prescription after myocardial infarction (MI) is recommended for all eligible patients. Numerous beta-blocker choices are presently available with variable glycometabolic effects, which could be an important consideration in patients with diabetes mellitus (DM). Wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Arnold, Suzanne V., Spertus, John A., Lipska, Kasia J., Lanfear, David E., Tang, Fengming, Grodzinsky, Anna, McGuire, Darren K., Gore, M. Odette, Goyal, Abhinav, Maddox, Thomas M., Kosiborod, Mikhail
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4151261/
https://ncbi.nlm.nih.gov/pubmed/25173537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2014.04.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados